Pharma minutes

Sunday 18 March 2018

Labels: Job

FDA approves drug to treat Duchenne muscular dystrophy

The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and o...
Trump Volatility Index Takes Pharma Companies on a Wild Ride

Few industries are getting the Trump Treatment quite like Big Pharma. Drug stocks initially jumped after Donald Trump was elected, on ...
Big Pharma’s Offer to Trump: Discounts When Drugs Don’t Work- Must read

President Donald Trump says drug prices are astronomical and something needs to be done. Pharmaceutical giants have an answer that doesn’t...
Granules to invest $20 mn in US subsidiary Granules Pharmaceulticals Inc, Q3 net up 34% at Rs. 39 cr

Granules India Ltd has announced its move to invest $20 million in its wholly-owned subsidiary Granules Pharmaceulticals Inc. The comp...
Alembic Pharma slips 3% as Q3 net tumbles- Eighth time in the past 10 sessions

Continuing its losing streak for the eighth time in the past 10 sessions, shares of Alembic Pharmaceuticals fell 3 per cent in morning tr...

Simple theme. Powered by Blogger.